Literature DB >> 15629357

Epitope analysis for influenza vaccine design.

Enrique T Muñoz1, Michael W Deem.   

Abstract

Until now, design of the annual influenza vaccine has relied on phylogenetic or whole-sequence comparisons of the viral coat proteins hemagglutinin and neuraminidase, with vaccine effectiveness assumed to correlate monotonically to the vaccine-influenza sequence difference. We use a theory from statistical mechanics to quantify the non-monotonic immune response that results from antigenic drift in the epitopes of the hemagglutinin and neuraminidase proteins. The results explain the ineffectiveness of the 2003-2004 influenza vaccine in the United States and provide an accurate measure by which to optimize the effectiveness of future annual influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629357      PMCID: PMC4482133          DOI: 10.1016/j.vaccine.2004.08.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Update: influenza activity--United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-05-14       Impact factor: 17.586

2.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

3.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Update: influenza activity--United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-05-05       Impact factor: 17.586

5.  Sequence space localization in the immune system response to vaccination and disease.

Authors:  Michael W Deem; Ha Youn Lee
Journal:  Phys Rev Lett       Date:  2003-08-07       Impact factor: 9.161

6.  Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.

Authors:  W R Tulip; J N Varghese; A T Baker; A van Donkelaar; W G Laver; R G Webster; P M Colman
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

7.  Update: influenza activity--United States and Worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-04-26       Impact factor: 17.586

8.  Update: influenza activity--United States and worldwide, 1994-95 season, and composition of the 1995-96 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-04-21       Impact factor: 17.586

9.  Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.

Authors:  G M Air; M C Els; L E Brown; W G Laver; R G Webster
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

10.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  35 in total

1.  Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.

Authors:  E M Abdelwhab; Abdel-Satar Arafa; Jürgen Stech; Christian Grund; Olga Stech; Marcus Graeber-Gerberding; Martin Beer; Mohamed K Hassan; Mona M Aly; Timm C Harder; Hafez M Hafez
Journal:  Virus Genes       Date:  2012-06-05       Impact factor: 2.332

2.  Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.

Authors:  Ruth V Bushnell; John K Tobin; Jinxue Long; Stacey Schultz-Cherry; A Ray Chaudhuri; Peter L Nara; Gregory J Tobin
Journal:  Virol J       Date:  2010-08-24       Impact factor: 4.099

3.  Ab and T cell epitopes of influenza A virus, knowledge and opportunities.

Authors:  Huynh-Hoa Bui; Bjoern Peters; Erika Assarsson; Innocent Mbawuike; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-02       Impact factor: 11.205

4.  Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.

Authors:  Wai Lan Wu; Yixin Chen; Pui Wang; Wenjun Song; Siu-Ying Lau; Jane M Rayner; Gavin J D Smith; Robert G Webster; J S Malik Peiris; Tianwei Lin; Ningshao Xia; Yi Guan; Honglin Chen
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

5.  A genotype network reveals homoplastic cycles of convergent evolution in influenza A (H3N2) haemagglutinin.

Authors:  Andreas Wagner
Journal:  Proc Biol Sci       Date:  2014-07-07       Impact factor: 5.349

6.  Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.

Authors:  Nipaporn Tewawong; Nungruthai Suntronwong; Preeyaporn Vichiwattana; Sompong Vongpunsawad; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Virus Genes       Date:  2016-05-04       Impact factor: 2.332

Review 7.  Theoretical aspects of immunity.

Authors:  Michael W Deem; Pooya Hejazi
Journal:  Annu Rev Chem Biomol Eng       Date:  2010       Impact factor: 11.059

8.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

9.  Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.

Authors:  Richard A Neher; Trevor Bedford; Rodney S Daniels; Colin A Russell; Boris I Shraiman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

10.  Projection of seasonal influenza severity from sequence and serological data.

Authors:  Yuri I Wolf; Anastasia Nikolskaya; Joshua L Cherry; Cecile Viboud; Eugene Koonin; David J Lipman
Journal:  PLoS Curr       Date:  2010-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.